Clinical Trials Logo

Altitude Sickness clinical trials

View clinical trials related to Altitude Sickness.

Filter by:

NCT ID: NCT04604249 Active, not recruiting - Covid19 Clinical Trials

Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World

RINCOVID
Start date: October 26, 2020
Phase:
Study type: Observational

Since the beginning of 2020, SARS-CoV-2 outbreak spread over the world, conducting in a pandemic state declared by the world health organization in March 2020. Conflicting data have been yet published regarding to the incidence rate of COVID-19 infection in altitude. Mainly based on analysis from national Peru database, some authors argued that COVID-19 disease, as well as case fatality rate was less frequent in altitude. However, epidemiological data are lacking regarding to the prevalence of COVID-19 in altitude, and more specially in high altitude. Aim of this cross-sectional study is to assess the prevalence of seroconversion for the SARS-CoV-2 in the population of La Rinconada, a mining town at 5,100 m, the highest city in the world.

NCT ID: NCT04557995 Recruiting - Clinical trials for High Altitude Polycythemia

Clinical Efficacy of Erythropheresis in High Altitude Polycythemia

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The clinical study is aimed to explore the efficacy and safety of erythropheresis in high altitude polycythemia.

NCT ID: NCT04491500 Completed - Clinical trials for High Altitude Retinopathy

Retinal and Choroidal Circulation Changes Following Rapid Ascent to a High Altitude Environment

Start date: July 27, 2020
Phase:
Study type: Observational

This is a prospective observational study. The purpose is to explore the effect of high altitude hypobaric hypoxia on retinal microcirculation and the change of the thickness of the retina and choroid by optical coherence tomography angiography (OCTA).

NCT ID: NCT04290481 Completed - High Altitude Clinical Trials

Oxygen Saturation and Perfusion Index ın Neonates at High Altitude

Start date: June 1, 2018
Phase:
Study type: Observational

Congenital heart diseases are among the most common congenital anomalies and occur with an incidence of approximately 8ınd12 / 1,000 live births worldwide. This figure does not cover minor lesions such as bicuspid aortic valves and small atrial or ventricular septal defects. Most of these defects do not need treatment or treatment is needed after infancy. Other defects are severe and usually require early treatment in the neonatal period. Critical congenital heart disease is defined as structural heart defects that are associated with hypoxia in the neonatal period and have significant morbidity and mortality potential in early life. Critical congenital heart disease is estimated to be ~3 in 1000 live births. It is estimated that 50% of congenital heart diseases are detected by prenatal ultrasound. Even if a standard neonatal examination is performed, 13 to 55% of patients with critical congenital heart disease can be discharged from the hospital without being diagnosed. Screening of infants with non-invasive oxygen saturation measurement has been proposed as an adjunct to early detection of critical congenital heart disease. The American Academy of Pediatrics, the American Cardiology Foundation and the American Heart Association have targeted 7 specific lesions for the pulse oximetry screening protocol: truncus arteriosus, transposition of the great arteries, tricuspid atresia, tetralogy of Fallot, total pulmonary venous return anomaly, hypoplastic left heart syndrome and pulmonary atresia. The reference values of peripheral perfusion (PPI) index has been established for normal newborns between 1 and 120 h of age. Lower PPI values than 0.70 may indicate illness. Including cut-off values for PPI in pulse-oximetry screening for duct dependent congenital heart disease is a promising tool for improving the detection of critical congenital heart disease with duct-dependent systemic circulation. We aimed to investigate screening critical congenital heart disease and also to establish normal values of oxygen saturation and perfusion index at high altitude.

NCT ID: NCT04288219 Recruiting - Hypoxia Clinical Trials

Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Trial of Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

NCT ID: NCT04251364 Recruiting - Hypoxia, Altitude Clinical Trials

Treatment of Chronic Mountain Sickness

Exp5300
Start date: February 15, 2020
Phase: N/A
Study type: Interventional

This study aims to assess the effect of two drugs for the treatment of chronic mountain sickness in highlanders.

NCT ID: NCT04186598 Completed - Clinical trials for Continuous Positive Airway Pressure

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the efficacy of continuous positive pressure on resolution of high-altitude pulmonary edema vs high flow oxygen. The secondary objective is to derive an incidence of high-altitude pulmonary edema based on the elevation and timing from which the subject arrives. Additionally, in a convenience sample of the base study population, an ultrasound evaluation for the presence of B lines in the lungs will be conducted after 2 hours.

NCT ID: NCT04111263 Completed - Clinical trials for Acute Mountain Sickness

Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

Start date: October 6, 2019
Phase: N/A
Study type: Interventional

The aim of this randomized, crossover clinical trial is to determine the efficacy of a gut microbiota-targeted nutritional intervention containing a blend of fermentable fibers and polyphenols (FP) for mitigating increases in GI permeability, and decrements in immune function and neuropsychologic performance following rapid ascent to simulated high altitude. Fifteen healthy young adults will participate in each of three study phases that include a 14-day supplementation period in which participants will consume 1 of 2 supplement bars: placebo (PL, will be consumed during 2 phases) and FP supplementation (will be consumed during one phase only). During the final 2-d of each phase, participants will live in a hypobaric chamber under sea level or high altitude conditions.

NCT ID: NCT04089410 Completed - Quality of Life Clinical Trials

Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status

Start date: January 14, 2019
Phase: N/A
Study type: Interventional

Life expectancy and quality of human life are important indicator of the sustainable development of the society. At the same time, the physical, functional, emotional and psychological components of the of the quality of life evaluation are subjected to be evaluated objectively and corrected using modern medical and socio-psychological methods. According to a fair number of experts, the arsenal of means for functional rehabilitation and health promotion is limited, and its expansion is only possible on the basis of the principles of adaptation medicine and their translation from experimental research into specific preventive and health-promoting technologies. The study is aimed at the development in molecular-endocrine, neuro-visceral and psychophysiological complex mechanisms of human long-term adaptation to systemic modern heating device-based hyperthermia for the development of medical technology focused on optimization in physical functioning, neuro-autonomic regulation, psycho-emotional status and stress- resistance as objective characteristics of humans' quality of life in working age. The novelty of the project is the disclosure of key mechanisms of adaptational direct and cross-effects to the prolonged systemic individually dosed hyperthermia underlying the optimization of stress-resistance, psycho-physiological status and exercise tolerance of practically healthy persons and leading to an increase in the subjectively perceived quality of life. The discovery of the mechanisms of hyperthermically induced neuroplasticity (in terms of the dynamics of oxidative stress, heat shock proteins and the brain derived neurotrophic factor) will also have a scientific significance, which in the long term prospectives may play a role in the development of technics for the prevention and rehabilitation of age-associated neuro-degenerative processes and diseases.

NCT ID: NCT04075565 Completed - Hypoxia Clinical Trials

The Psychophysiological Effect of Simulated and Terrestrial Altitude

Hypoxia
Start date: June 24, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to compare the psychophysiological effects of terrestrial altitude with a normobaric, hypoxic situation.